UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 750

Sortiert nach

Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups

Bratislavské lékarské listy, 2020, Vol.121 (7), p.462-465

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of major depressive disorder on the short‐ and long‐term outcome of Crohn's disease treatment with infliximab

Alimentary pharmacology & therapeutics, 2005-07, Vol.22 (2), p.101-110

2005

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology and risk factors for cholelithiasis in patients with Crohn's disease

Physiological research, 2019-01, Vol.68 (Suppl 2), p.S173-S182

2019

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease

Alimentary pharmacology & therapeutics, 2005-10, Vol.22 (7), p.613-626

2005

Link zum Volltext

Verfügbarkeit prüfen

Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease

Physiological research, 2019-01, Vol.68 (Suppl 2), p.S183-S192

2019

Link zum Volltext

Verfügbarkeit prüfen

Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment

Acta gastro-enterologica belgica, 2018-10, Vol.81 (4), p.465-470

2018

Link zum Volltext

Verfügbarkeit prüfen

Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy

Bratislavské lékarské listy, 2016, Vol.117 (4), p.205-211

2016

Link zum Volltext

Verfügbarkeit prüfen

Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patients

Bratislavské lékarské listy, 2018, Vol.119 (7), p.408-415

2018

Link zum Volltext

Verfügbarkeit prüfen

The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease

Bratislavské lékarské listy, 2013, Vol.114 (8), p.439-445

2013

Link zum Volltext

Verfügbarkeit prüfen

350 PREVALENCE OF PREVIOUSLY UNRECOGNIZED AND ASYMPTOMATIC NAFLD AMONG PATIENTS WITH METABOLIC RISK FACTORS

Journal of hepatology, 2010, Vol.52, p.S146-S146

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of point mutations in KRAS oncogene by real-time PCR-based genotyping assay in GIT diseases

Bratislavské lékarské listy, 2012, Vol.113 (2), p.73-79

2012

Link zum Volltext

Verfügbarkeit prüfen

The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases

Bratislavské lékarské listy, 2013, Vol.114 (4), p.199-205

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients

Bratislavské lékarské listy, 2013, Vol.114 (6), p.330-332

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients

Bratislavské lékarské listy, 2012, Vol.113 (5), p.282-284

2012

Link zum Volltext

Verfügbarkeit prüfen

P808 Prevalence and risk factors of cholelithiasis in patients with Crohn’s disease

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S526-S526

2019

Link zum Volltext

Verfügbarkeit prüfen

Positive family history promotes participation in colorectal cancer screening

Bratislavské lékarské listy, 2005, Vol.106 (10), p.318-323

2005

Link zum Volltext

Verfügbarkeit prüfen

P312 Trabecular bone score in patients with inflammatory bowel diseases

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S235-S236

2017

Link zum Volltext

Verfügbarkeit prüfen

P750 Prevalence and risk factors of cholelithiasis in patients with Crohn's disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S465-S466

2017

Link zum Volltext

Verfügbarkeit prüfen

P567 Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activity

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S369-S369

2017

Link zum Volltext

Verfügbarkeit prüfen

New Protocol for DNA Extraction of Stool

BioTechniques, 2000-02, Vol.28 (2), p.286-290

2000

Link zum Volltext

Verfügbarkeit prüfen

P590 An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S410-S410

2019

Link zum Volltext

Verfügbarkeit prüfen

Is there any role for prevention strategies for colorectal cancer other than population-based screening?

Bratislavské lékarské listy, 2004, Vol.105 (5-6), p.215-224

2004

Link zum Volltext

Verfügbarkeit prüfen

Heterotopic pancreas in gastric antrum with macroscopic appearance of gastric polyp

Bratislavské lékarské listy, 2002, Vol.103 (3), p.117-120

2002

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring in the treatment of inflammatory bowel disease with infliximab

Gastroenterologie a hepatologie, 2018-02, Vol.72 (1), p.41-46

2018

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

Clinical gastroenterology and hepatology, 2014-09, Vol.12 (9), p.1485-1493.e2

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 750

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(518)
Mit Volltextzugriff
(577)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups

The impact of major depressive disorder on the short‐ and long‐term outcome of Crohn's disease treatment with infliximab

Pathophysiology and risk factors for cholelithiasis in patients with Crohn's disease

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease

Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease

Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment

Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy

Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patients

The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease

350 PREVALENCE OF PREVIOUSLY UNRECOGNIZED AND ASYMPTOMATIC NAFLD AMONG PATIENTS WITH METABOLIC RISK FACTORS

Detection of point mutations in KRAS oncogene by real-time PCR-based genotyping assay in GIT diseases

The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases

Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients

Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients

P808 Prevalence and risk factors of cholelithiasis in patients with Crohn’s disease

Positive family history promotes participation in colorectal cancer screening

P312 Trabecular bone score in patients with inflammatory bowel diseases

P750 Prevalence and risk factors of cholelithiasis in patients with Crohn's disease

P567 Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activity

New Protocol for DNA Extraction of Stool

P590 An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab

Is there any role for prevention strategies for colorectal cancer other than population-based screening?

Heterotopic pancreas in gastric antrum with macroscopic appearance of gastric polyp

Therapeutic drug monitoring in the treatment of inflammatory bowel disease with infliximab

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

Suchergebnisse filtern